Matthew Navarro

CFO

Matthew Navarro is an experienced executive with over 15 years in the life sciences industry. He was most recently President and Chief Financial Officer of Glympse Bio where he led finance & accounting, operations, corporate strategy, business development and investor relations. He played a pivotal role in Glympse Bio's successful merger with Sunbird Bio. Prior to Glympse Bio, Matthew was a Managing Director in the Healthcare Group at Perella Weinberg Partners, where he focused on providing strategic and financial advice to life sciences companies. He began his investment banking career at Lehman Brothers and held roles at Barclays and Morgan Stanley.

Matthew holds a Master of Business Administration and a Juris Doctor from the University of North Carolina.